| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $178.3M | +3.6% | +7.5% |
| Cost of Revenue | $44.4M | +4.1% | +8.0% |
| Gross Profit | $133.9M | +3.5% | +7.3% |
| R&D Expense | $27.3M | -2.3% | +6.6% |
| SG&A Expense | $29.2M | +3.8% | +3.5% |
| Operating Income | $7.6M | +0.8% | -9.0% |
| Pre-tax Income | $13.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $419.9M | -8.5% | -42.1% |
| Accounts Receivable | $155.6M | -11.1% | +14.0% |
| Current Assets | $983.8M | -6.9% | -2.9% |
| Total Assets | $1.70B | -5.0% | +0.5% |
| Current Liabilities | $646.9M | +0.5% | +71.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $142.9M | — | — |
| Capital Expenditures | $7.5M | — | — |
| Investing Cash Flow | -$403.5M | — | — |
| Financing Cash Flow | -$205.9M | — | — |
| Free Cash Flow | $135.4M | — | — |
| -2.2% |
| -20.4% |
| Income Tax | $4.7M | -24.7% | +121.5% |
| Net Income | $5.3M | -36.3% | -69.3% |
| EPS (Basic) | $0.09 | -30.8% | -67.9% |
| EPS (Diluted) | $0.09 | -30.8% | -66.7% |
| $1.34B |
| -0.5% |
| +3.1% |
| Stockholders' Equity | $328.3M | -20.7% | -10.8% |